CervoMed (CRVO) vs Hyperion DeFi (HYPD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Hyperion DeFi (HYPD) has outperformed CervoMed (CRVO) over the past year, losing 61.6% versus a loss of 62.7%. Over five years, CRVO leads with a -91.2% price change compared with -99.2% for HYPD. Hyperion DeFi is the larger company by market cap ($51.2 million vs $49.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRVO | HYPD |
|---|---|---|
| Share price | $3.28 | $3.37 |
| Market cap | $49.59M | $51.16M |
| 1-day change | +3.14% | -6.27% |
| YTD return | -59.75% | +0.84% |
| 1-year return | -62.72% | -61.60% |
| 5-year return | -91.17% | -99.15% |
| EPS (TTM) | $-3.21 | $-6.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.00 | $9.50 |
| 52-week low | $2.13 | $2.34 |
| Distance from 52-week high | -67.20% | -64.58% |
| Average volume | 339.98K | 445.34K |
| Shares outstanding | 15.12M | 15.20M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CRVO vs HYPD FAQ
Which is bigger, CervoMed or Hyperion DeFi?
Hyperion DeFi (HYPD) is larger, with a market capitalization of $51.16M compared with $49.59M for CervoMed (CRVO).
Which stock has performed better over the past year, CRVO or HYPD?
HYPD returned -61.60% over the past 12 months, compared with -62.72% for CRVO (price return, excluding dividends). Past performance does not predict future results.
Are CervoMed and Hyperion DeFi in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.